Apotex Corp. is recalling 644,502 bottles of Brimonidine Tartrate/Timolol Maleate and Ketorolac Tromethamine eye drops because some bottles may not be properly sealed. This improper sealing can lead to the medicine losing its sterility or leaking, which was noticed during testing as an unusual loss of weight in the bottles. The recall affects several lots of prescription eye drops used to treat eye pressure and inflammation.
If an eye drop solution is not sterile, it can become contaminated with bacteria or other germs. Using contaminated eye drops directly on the eye can lead to serious eye infections, which could potentially cause permanent vision loss or other severe health complications.
You have 2 options:
Manufactured by Apotex Inc., Richmond Hill, Ontario, Canada.
Manufactured by Apotex Inc., Richmond Hill, Ontario, Canada.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.